Zobrazeno 1 - 10
of 202
pro vyhledávání: '"G. N. Hortobagyi"'
Autor:
E, Rivera, V, Valero, L, Syrewicz, Z, Rahman, F J, Esteva, R L, Theriault, M M, Rosales, D, Booser, J L, Murray, R C, Bast, G N, Hortobagyi, F L, Esteva
Publikováno v:
Journal of Clinical Oncology. 19:1716-1722
PURPOSE: We conducted a single-institution phase I clinical trial to determine the maximum-tolerated dose (MTD) and define the toxic effects of stealth liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer. P
Abstracts from the symposium on recent advances in Paget’s disease of bone and related bone diseases
Autor:
Allan Lipton, Allen M. Spiegel, M. Heffernan, Michael P. Whyte, J. L. Doppman, Stanley Wallach, Ethel S. Siris, P. J. Meunier, Toshiyuki Yoneda, Henry G. Bone, Roy D. Altman, S. Martinez, R. Knight, R. Theriault, Samuel A. Wells, J. J. Eckardt, J. Seaman, Melvin M. Grumbach, E. J. A. Gerritsen, Will G. Ryan, C. C. Chen, Gordon B. Cutler, D. Reitsma, G. N. Hortobagyi, William L. Ries, L. L. Key, Felix A. Conte, Orlo H. Clark, Penelope Feuillan, Janet Jones, G. A. W. Gooding, F. S. Kaplan, Michael R. McClung, Frederick R. Singer, H. Watts, Selna L. Kaplan, Francis H. Glorieux, P. Z. Wirganowicz, D. Sudhaker Rao, Pierre D. Delmas, Roland Chapurlat, J. P. Bilezikian
Publikováno v:
Calcified Tissue International. 59:219-227
Autor:
D. J. Weisenberger, B. N. Trinh, M. Campan, S. Sharma, T. I. Long, S. Ananthnarayan, G. Liang, F. J. Esteva, G. N. Hortobagyi, F. McCormick, P. A. Jones, P. W. Laird
Publikováno v:
Nucleic Acids Research
Alterations in cytosine-5 DNA methylation are frequently observed in most types of human cancer. Although assays utilizing PCR amplification of bisulfite-converted DNA are widely employed to analyze these DNA methylation alterations, they are general
Autor:
T. Rizzo, G. N. Hortobagyi
Publikováno v:
MD Conference Express. 12:6-7
Autor:
B, Wang, R, Rouzier, C T, Albarracin, A, Sahin, P, Wagner, Y, Yang, T L, Smith, F, Meric-Bernstam, C, Marcelo Aldaz, A C, Marcelo, G N, Hortobagyi, L, Pusztai
Publikováno v:
Breast cancer research and treatment. 87(3)
The sigma 1 receptor (S1R) represents a unique drug-binding site that is distinct from any other receptors. We examined S1R expression in human breast cancer and assessed the activity of S1R ligands in breast cancer cell lines. One-hundred nine breas
Autor:
J. C. Piette, D. Buthiau, D. Grosskopf, Y. Darbois, G. N. Hortobagyi, J.M. Ziza, G. Delépine, F. Bolgert, P. Lapresle, B. Wechsler, A. Ducolombier, G. Lefebvre, G. Michaux, D. Dargent, J.-D. Picard, M. Dousset, C. Dugas, N. Delépine, D. Khayat
Publikováno v:
Virtual Endoscopy ISBN: 9782287596582
Technical improvements in high resolution CT acquisition and fast imaging MR imaging, coupled with advanced 2D or 3D computer graphics, have permitted interactive 3D visualization in medical imaging.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::201480ba41764302a95512196bf7436e
https://doi.org/10.1007/978-2-8178-0203-9_1
https://doi.org/10.1007/978-2-8178-0203-9_1
Autor:
G N, Hortobagyi
Publikováno v:
Seminars in oncology. 28(6 Suppl 18)
HER2/neu amplification/overexpression confers more aggressive and malignant characteristics on breast cancer cells. Patients with HER2/neu-amplified breast cancer have a worse prognosis than those with normal HER2/neu expression. Over the past decade
Autor:
M, Cristofanilli, A U, Buzdar, N, Sneige, T, Smith, B, Wasaff, N, Ibrahim, D, Booser, E, Rivera, J L, Murray, V, Valero, N, Ueno, E S, Singletary, K, Hunt, E, Strom, M, McNeese, C, Stelling, G N, Hortobagyi
Publikováno v:
Cancer. 92(7)
Inflammatory breast carcinoma (IBC) is a rare but aggressive form of breast carcinoma. Anthracycline-based regimens represent the standard of treatment for IBC. Reports of significant clinical activity of paclitaxel in metastatic breast carcinoma led
Autor:
Q, Xiong, V, Valero, V, Kau, S W, Kau, S, Taylor, T L, Smith, A U, Buzdar, G N, Hortobagyi, R L, Theriault
Publikováno v:
Cancer. 92(10)
The objective of this study was to analyze the outcome of treatment in young women with breast carcinoma who were treated at a single institution and to develop a clearer understanding of the natural history of the disease in these women.One hundred
Autor:
T A, Buchholz, B S, Hill, S L, Tucker, D K, Frye, H M, Kuerer, A U, Buzdar, M D, McNeese, S E, Singletary, N T, Ueno, L, Pusztai, V, Valero, G N, Hortobagyi
Publikováno v:
Cancer journal (Sudbury, Mass.). 7(5)
The purpose of this study was to determine the clinical, pathological, and treatment factors that are predictive of local-regional recurrence and overall survival for patients with breast cancer that is refractory to neoadjuvant chemotherapy.This stu